Radioprotection by whole body hyperthermia: Possible mechanism(s)

Journal of Thermal Biology

Volumn 27, Issue 1, 2002, Pages 29-37

  Zaidi, A K ^a   Patil, M S ^a   Bagewadikar, R S ^a   Subramanian, M ^a   Kaklij, G S ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

Cellularity; Cytokines; Radioprotection; Spleen colony formation; Total body irradiation; Whole body hyperthermia

Indexed keywords

EID: 0036144811     PISSN: 03064565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4565(01)00012-2     Document Type: Article

References (42)

1. Decreased X-ray mortality in endotoxin treated mice
2. Cytokine induction in human by 41.8°C whole body hyperthermia
3. Hyperthermia in humans enhances interferon-γ synthesis and alters the peripheral lymphocyte population
4. Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin-1 and tumor necrosis factor
5. Recombinant tumor necrosis factor and interleukin-1 both stimulate human synovial cell arachidonic acid release and phospholipid metabolism
6. 2 production
7. Cytokine production after whole body and localized hyperthermia
8. In vivo effect of interleukin-1α on hematopoiesis: Role of colony stimulating factor receptor modulation
9. In vivo hematopoietic effects of recombinant interleukin-1α in mice: Stimulation of granulocytic, monocytic, megakaryocytic and early erythroid progenitors, suppression of late stage erythropoiesis and reversal of erythroid suppression with erythropoietin
10. Whole body hyperthermia cytokine induction: A review, and unifying hypothesis for myeloprotection in the setting of cytotoxic therapy
11. Implications of 41.8°C whole body hyperthermia cytokine induction to cytotoxic therapy and bone marrow transplantation
12. Prostaglandins as endogenous mediators of interleukin-1 production
13. 2
14. Modification of irradiation injury in mice and guinea pigs by bone marrow injection
15. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor bearing mice
16. Comparison of leukocytic pyrogen and leukocytic endogenous mediator
17. The molecular biology and function of the granulocyte macrophage colony stimulating factor
18. Recombinant human TNF induces production of granulocyte-monocyte colony stimulating factor
19. Interleukin-1 is a radioprotector
20. Radioprotection by IL-I
21. Interdependence of the radioprotective effects of human recombinant interleukin-1, tumor necrosis factor, granulocyte colony stimulating factor and murine recombinant granulocyte macrophage colony stimulating factor
22. Role of cytokines (interleukin-1, tumor necrosis factor and transforming growth factor-β) in natural and lipopolysaccharide enhanced radioresistance
23. Role of interleukin-6 in protection from lethal irradiation and in endocrine responses to interleukin-1 and tumor necrosis factor
24. The in vivo effects of interleukin-1. I. Bone marrow cells are induced to cycle after administration of interleukin-1
25. Comparison of in vivo effects of human recombinant IL-1 and human recombinant IL-6 in mice
26. There is more then one IL-1
27. Survival enhancement and hemopoietic regeneration following radiation exposure: Therapeutic approach using glucan and granulocyte colony-stimulating factor
28. Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation induced hematopoietic depression
29. Radioprotective effect of whole body hyperthermia on mice exposed to lethal doses of gamma radiation
30. Cytotoxic interactions of tumor necrosis factor, melphalan, and 41.8°C hyperthermia
31. Cytokine induction by 41.8°C whole body hyperthermia
32. Whole body hyperthermia combined with total body irradiation and chemotherapy as a preparative regimen for allogeneic bone marrow transplantation in a patient with Burkitt's lymphoma
33. Adjunctive therapy (whole body hyperthermia vs lonidamine) to total body irradiation for the treatment of favorable B cell neoplasms: A report of two pilot clinical trials and laboratory investigations
34. Phase I clinical trial of melphalan (L-PAM) and 41.8°C whole body hyperthermia (WBH) in cancer patients
35. Enhanced hematopoietic recovery in irradiated mice pre-treatment with interleukin-1
36. Whole body hyperthermia: A potent radioprotector in vivo
37. Cancer chemotherapy with TNF administration in human
38. Protective, restorative, and therapeutic properties of recombinant colony stimulating factors
39. Radioprotection of bone marrow stem cell subsets by interleukin-1 and kit ligand: Implications for CFU-S as the responsible target cell population
40. Induction of colony stimulating factor in vivo by recombinant interleukin-1α and recombinant tumor necrosis factor-α
41. Hematological effects of radiant heat induced whole body hyperthermia on dogs
42. Radiprotection of hematopoietic stem cells by interleukin 1